DECIBEL CANNABIS CO INC (DB.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:DB - CA2434371001 - Common Stock
0.1 CAD
0 (-4.76%)
DB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Pharmaceuticals industry. While DB is still in line with the averages on profitability rating, there are concerns on its financial health. DB is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- DB had negative earnings in the past year.
- In the past year DB had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: DB reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: DB reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.97%, DB belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
- With an excellent Return On Equity value of 18.35%, DB belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 18.35% | ||
| ROIC | N/A |
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DB has a better Profit Margin (10.67%) than 82.86% of its industry peers.
- In the last couple of years the Profit Margin of DB has grown nicely.
- DB has a worse Gross Margin (21.98%) than 65.71% of its industry peers.
- DB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 10.67% | ||
| GM | 21.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
2. Health
2.1 Basic Checks
- DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for DB has been increased compared to 1 year ago.
- The number of shares outstanding for DB has been increased compared to 5 years ago.
- The debt/assets ratio for DB has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.93, we must say that DB is in the distress zone and has some risk of bankruptcy.
- DB has a Altman-Z score of 0.93. This is in the better half of the industry: DB outperforms 65.71% of its industry peers.
- The Debt to FCF ratio of DB is 18.67, which is on the high side as it means it would take DB, 18.67 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 18.67, DB is doing good in the industry, outperforming 68.57% of the companies in the same industry.
- DB has a Debt/Equity ratio of 0.54. This is a neutral value indicating DB is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.54, DB is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 18.67 | ||
| Altman-Z | 0.93 |
ROIC/WACCN/A
WACC7.91%
2.3 Liquidity
- A Current Ratio of 1.34 indicates that DB should not have too much problems paying its short term obligations.
- The Current ratio of DB (1.34) is comparable to the rest of the industry.
- DB has a Quick Ratio of 1.34. This is a bad value and indicates that DB is not financially healthy enough and could expect problems in meeting its short term obligations.
- DB has a Quick ratio of 0.61. This is in the lower half of the industry: DB underperforms 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 816.22% over the past year.
- The Earnings Per Share has been growing by 90.70% on average over the past years. This is a very strong growth
- DB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.11%.
- DB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 71.51% yearly.
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%
3.2 Future
- The Earnings Per Share is expected to grow by 77.26% on average over the next years. This is a very strong growth
- Based on estimates for the next years, DB will show a quite strong growth in Revenue. The Revenue will grow by 10.49% on average per year.
EPS Next Y151%
EPS Next 2Y109.28%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue Next Year25.36%
Revenue Next 2Y22.27%
Revenue Next 3Y19.18%
Revenue Next 5Y10.49%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Forward Earnings ratio is 4.20, which indicates a rather cheap valuation of DB.
- Based on the Price/Forward Earnings ratio, DB is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 24.31. DB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 4.2 |
4.2 Price Multiples
- Based on the Price/Free Cash Flow ratio, DB is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.54 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- DB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as DB's earnings are expected to grow with 77.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.28%
EPS Next 3Y77.26%
5. Dividend
5.1 Amount
- No dividends for DB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:DB (1/15/2026, 7:00:00 PM)
0.1
0 (-4.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-19 2025-11-19/bmo
Earnings (Next)04-20 2026-04-20/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.84%
Ins Owner ChangeN/A
Market Cap57.69M
Revenue(TTM)109.31M
Net Income(TTM)11.66M
Analysts82
Price Target0.27 (170%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)7.97%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-13.84%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-5.36%
Revenue beat(12)5
Avg Revenue beat(12)1.08%
Revenue beat(16)5
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-60%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 4.2 | ||
| P/S | 0.53 | ||
| P/FCF | 23.54 | ||
| P/OCF | 14.58 | ||
| P/B | 0.91 | ||
| P/tB | 0.92 | ||
| EV/EBITDA | N/A |
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY23.8%
FCF(TTM)0
FCFY4.25%
OCF(TTM)0.01
OCFY6.86%
SpS0.19
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 18.35% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 10.67% | ||
| GM | 21.98% | ||
| FCFM | 2.24% |
ROA(3y)0.61%
ROA(5y)-1.43%
ROE(3y)0.45%
ROE(5y)-4.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.46%
PM growth 5YN/A
GM growth 3Y72.19%
GM growth 5Y-2.05%
F-Score6
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 18.67 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 23.63% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 21.01% | ||
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 0.93 |
F-Score6
WACC7.91%
ROIC/WACCN/A
Cap/Depr(3y)70.46%
Cap/Depr(5y)95.47%
Cap/Sales(3y)2.65%
Cap/Sales(5y)5.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)816.22%
EPS 3Y90.7%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y151%
EPS Next 2Y109.28%
EPS Next 3Y77.26%
EPS Next 5YN/A
Revenue 1Y (TTM)15.11%
Revenue growth 3Y20.83%
Revenue growth 5Y71.51%
Sales Q2Q%36.51%
Revenue Next Year25.36%
Revenue Next 2Y22.27%
Revenue Next 3Y19.18%
Revenue Next 5Y10.49%
EBIT growth 1Y-65.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year310.35%
EBIT Next 3Y86.3%
EBIT Next 5Y46.87%
FCF growth 1Y-16.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.82%
OCF growth 3YN/A
OCF growth 5YN/A
DECIBEL CANNABIS CO INC / DB.CA FAQ
What is the ChartMill fundamental rating of DECIBEL CANNABIS CO INC (DB.CA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to DB.CA.
What is the valuation status of DECIBEL CANNABIS CO INC (DB.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to DECIBEL CANNABIS CO INC (DB.CA). This can be considered as Fairly Valued.
How profitable is DECIBEL CANNABIS CO INC (DB.CA) stock?
DECIBEL CANNABIS CO INC (DB.CA) has a profitability rating of 4 / 10.
Can you provide the expected EPS growth for DB stock?
The Earnings per Share (EPS) of DECIBEL CANNABIS CO INC (DB.CA) is expected to grow by 151% in the next year.